(-0.42%) 5 125.25 points
(-0.42%) 38 396 points
(-0.53%) 17 810 points
(0.63%) $83.15
(0.25%) $2.04
(-1.77%) $2 315.90
(-3.49%) $26.70
(-1.63%) $945.80
(0.14%) $0.934
(0.59%) $11.05
(0.35%) $0.799
(-0.02%) $93.28
-0.99% CHF 30.10
Live Chart Being Loaded With Signals
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products...
Stats | |
---|---|
Volumen de hoy | 2 879.00 |
Volumen promedio | 63 835.00 |
Capitalización de mercado | 992.38M |
EPS | CHF0 ( 2024-03-12 ) |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | -19.67 |
ATR14 | CHF0.0800 (0.27%) |
Volumen Correlación
PolyPeptide Group AG Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PolyPeptide Group AG Correlación - Moneda/Commodity
PolyPeptide Group AG Finanzas
Annual | 2023 |
Ingresos: | CHF320.37M |
Beneficio Bruto: | CHF4.64M (1.45 %) |
EPS: | CHF-1.560 |
FY | 2023 |
Ingresos: | CHF320.37M |
Beneficio Bruto: | CHF4.64M (1.45 %) |
EPS: | CHF-1.560 |
FY | 2022 |
Ingresos: | CHF280.98M |
Beneficio Bruto: | CHF51.99M (18.50 %) |
EPS: | CHF0.240 |
Financial Reports:
No articles found.
PolyPeptide Group AG
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico